Navigation Links
The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML
Date:1/22/2009

WHITE PLAINS, N.Y. and PRINCETON, N.J., Jan. 22 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Celator Pharmaceuticals, Inc. today announced a partnership to support Phase 2 development of Celator's lead product candidate CPX-351 (Cytarabine:Daunorubicin) Liposome Injection for treatment of adults with acute myeloid leukemia (AML).

Through the partnership, LLS will provide $3.7 million to support Celator's Phase 2B multicenter, randomized, open-label trial of CPX-351 versus intensive salvage therapy in adult patients less than or equal to 60 years of age with AML in first relapse. Celator expects to start patient enrollment in this study in the first quarter of 2009 in the United States and Canada.

The partnership between Celator and LLS is part of LLS's Therapy Acceleration Program (TAP), which supports private sector and academic-based projects with the goal of advancing investigational therapies with high prospects for providing near-term benefit to patients with blood cancers.

"Celator has discovered a novel way to deliver and enhance the activity of agents that have been the standard of care in AML for decades," said Louis DeGennaro, Ph.D., LLS's chief scientific officer. "There have been many attempts to improve outcomes in this patient population with little success. The data collected on CPX-351 to date, and the enthusiasm of clinical investigators involved in that research, suggest that Celator's approach holds real promise to advance the treatment of AML."

"We are very pleased that The Leukemia & Lymphoma Society sees the potential of CPX-351 and is making this substantial investment," said Scott Jackson, chief executive officer, Celator Pharmaceuticals. "LLS has created a well defined, streamlined process for accessing capital for promising new blood cancer treatments. This commitment enhances our ability to further the clinical development of CPX-351
'/>"/>

SOURCE Celator Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. September is Leukemia, Lymphoma and Myeloma Awareness Month
5. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
6. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
7. Leukemia Drug Proves Safe and Effective Over the Long Term
8. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
11. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...LES, December 2 Fountain...that it would initiate a programme of,regular upda...significant,progress which Fountain is making in t...provide shareholders with regular updates on the p...rs and others. , Fountain reports that it...
(Date:12/2/2009)...2 With the addition of a Manhattan... H. Ekblom, LeClairRyan,s medical malpractice defe...n the New York market. Mr. Ekblom, a former state ...g ophthalmology-related malpractice claims. ,, ...ical malpractice defense attorneys located in LeCl...
(Date:12/2/2009)..., Mass. and HEIDELBERG, Germany, Dec. 2 /PRNewswir... of the winners of the "Top 10 Innovations of 2009...ated sequence capture technology for high-throughp...combinations of invention, vision and utility. ,...ges to evaluate a broad range of life science tech...
Breaking Medicine Technology:Fountain Healthy Aging Inc Business Update For Shareholders 2Fountain Healthy Aging Inc Business Update For Shareholders 3Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 2Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 3The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 1United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 2United Spinal Associations 2009 Independence Expo Aug 7th 8th in Orlando 3A Improving Life for the Disabled and the Aging 52079 3Cord Blood America Highlights Significant 2009 Progress 52075 1Cord Blood America Highlights Significant 2009 Progress 52075 2Cord Blood America Highlights Significant 2009 Progress 52075 3Cord Blood America Highlights Significant 2009 Progress 52075 4Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent Safe Topical Anti Androgens 13080 1Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent Safe Topical Anti Androgens 13080 2Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent Safe Topical Anti Androgens 13080 3
...n reduced by 40 percent compared,to delayed treatm...Pharma AG,Germany, announced today new data, whic... (interferon beta-1b) treatment in,patients with a...,can significantly reduce the risk of permanent ne...Disability Status Scale,(EDSS) by 40 percent over ...
...ey Endpoint in Primate Study, CHICAGO, May 02, 200... Holdings, Inc. today announced that its novel res...effective in preventing,inhalation anthrax infecti...dy where a 30-day course of oral Cethromycin was 1...thrax as compared to,the standard of care, Cipro(R...
Other Medicine Technology:Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 2Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 3Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability 4Cethromycin Shown Effective Against Anthrax in Study 2Cethromycin Shown Effective Against Anthrax in Study 3Cethromycin Shown Effective Against Anthrax in Study 4
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Kinase Inhibitors: Global ...6819/Kinase-Inhibitors-Global-Markets.html ,...for the years 2005 through 2008, and projections f...GRs) through 2014 ,, An overview of the market...
(Date:12/2/2009)...h Korea, Dec. 2 The Cit...lecom (KT), MacroEye and Qualcomm Incorporated (Na...iative, today announced the expansion of a project...ations through the "Seoul Family Helper" program. ... to caregivers and senior citizens in order to pro...
(Date:12/2/2009)...sty within 90 minutes of hospital arrival, study f...ws) -- A nationwide program to get faster treatmen...tack has dramatically reduced the time between hos...e than three-quarters of people with STEMI heart a...am pattern that shows major blockage of a heart ar...
(Date:12/2/2009)...ife remains unclear, researchers say , ,...h suggests that enzyme replacement therapy can mak...abry disease, a rare illness that affects the kidn...e, linked to the lack of an enzyme that helps meta...because it boosts the risk for a stroke, heart att...
(Date:12/2/2009)...c. 2 In the wake of the...aminated with a plastics chemical linked to birth ...iately to protect infants and mothers. ,, The H...enol A, or BPA, in food and beverage containers. T...nd Rep. Edward Markey of Massachusetts, would prot...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 2Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 4Health News:Heart Attack Treatment Speeds Up Nationwide 2Health News:Heart Attack Treatment Speeds Up Nationwide 3Health News:Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA 2
... Professor Ian Frazer of the University of Queensl...'s Fellowship. The prestigious Fellowship comes on...for his work in developing a vaccine for cervical ...logy and Cancer Research at Brisbane’s Princess Al...
... published in the issue of International Journal o...rease the risk of cervical cancer in women//. ...earchers with the International Collaboration of E... In addition, researchers found that the ris...
...o a new study, most women who have a breast remove...their decision.// 519 women who'd had cance...emoved in order to avoid a recurrence were surveye...led by Dr. Ann M. Geiger of Wake Forest University...
...o a senior Guangdong health official of China the ...r's peak human bird flu season in the province.// ... other health specialists. The senior health...d, "The weather has begun to get warmer and lowere...
... various phases of their life like education, marr...icials say that they do not plan for the most impo...tor of Ethics Institute for the University of New ...st amazes me," she said. The Institute has a biome...
...the lesser mortals, with a lower life expectancy, ...ng for the fair-sex. //In 2006 especially, there a...of women the world over, so much so that they seem...ountries, with lifestyles and smoking patterns bei...
Other Medicine News:Health News:Plan for Death, Health Center Advises People 2
Olympus osYris AutoPPI™
IMAGETEAM™ 4600PDF
...tband ideal for positive patient identification an...closures provide a secure seal, with five colors p...for use with Zebra printers for peak performance. ... photos. Flexible and latex-free, waterproof, with...
DataMate Laser Label Sheets for Insert Wristbands
Medicine Products: